Structural aspects of digestion of medium chain triglycerides studied in real time using sSAXS and Cryo-TEM

Pharmaceutical Research

Volumn 30, Issue 12, 2013, Pages 3088-3100

  Phan, Stephanie ^a   Hawley, Adrian ^b   Mulet, Xavier ^a,c   Waddington, Lynne ^c   Prestidge, Clive A ^d   Boyd, Ben J ^a  

^a MONASH UNIVERSITY   (Australia)

^b AUSTRALIAN SYNCHROTRON   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

cryogenic transmission electron microscopy; in vitro lipolysis; lipid digestion; lipid based drug delivery; synchrotron small angle X ray scattering

Indexed keywords

BILE SALT; LAURIC ACID; LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; OCTANOIC ACID; OCTANOIN; TRIACYLGLYCEROL LIPASE; TRIOCTANOIN;

ARTICLE; CHEMICAL STRUCTURE; CRYOGENIC TRANSMISSION ELECTRON MICROSCOPY; DRUG DELIVERY SYSTEM; ENZYME INHIBITION; IN VITRO STUDY; LIPID ANALYSIS; LIPOLYSIS; MICELLE; MOLECULAR EVOLUTION; NANOANALYSIS; PRIORITY JOURNAL; PROCESS MONITORING; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY;

COLLOIDS; CRYOELECTRON MICROSCOPY; DIGESTION; DRUG CARRIERS; HUMANS; LIPOLYSIS; MICROSCOPY, ELECTRON, TRANSMISSION; SCATTERING, SMALL ANGLE; TRIGLYCERIDES; X-RAY DIFFRACTION;

EID: 84890547432     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1108-2     Document Type: Article

References (38)

1. Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6(3):231-48.
2. Patton JS, Carey MC. Watching fat digestion. Science. 1979;204(4389):145-8.
3. Staggers JE et al. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of health adult human-beings. Biochemistry. 1990;29(8):2028-40.
4. Kossena GA et al. Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs. J Pharm Sci. 2003;92(3):634-48.
5. Kossena GA et al. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci. 2004;93(2):332-48.
6. Kossena GA et al. A novel cubic phase of medium chain lipid origin for the delivery of poorly water soluble drugs. J Control Release. 2004;99(2):217-29.
7. MacGregor KJ et al. Influence of lipolysis on drug absorption from the gastro-intestinal tract. Adv Drug Deliv Rev. 1997;25(1):33-46.
8. Hernell O, Staggers JE, Carey MC. Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2 Phase-analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human-beings. Biochemistry. 1990;29(8):2041-56.
9. Sek L et al. Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products. J Pharm Pharmacol. 2002;54(1):29-41.
10. Kaukonen AM et al. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharm Res. 2004;21(2):245-53.
11. Lee KWY, Porter CJH, Boyd BJ. The effect of administered dose of lipid-based formulations on the in vitro and in vivo performance of cinnarizine as a model poorly water-soluble drug. J Pharm Sci. 2013;102(2):565-78.
12. Embleton JK, Pouton CW. Structure and function of gastro-intestinal lipases. Adv Drug Deliv Rev. 1997;25(1):15-32.
13. Fatouros DG et al. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle x-ray scattering. Pharm Res. 2007;24(10):1844-53.
14. Salentinig S et al. Transitions in the internal structure of lipid droplets during fat digestion. Soft Matter. 2011;7(2):650-61.
15. Warren DB et al. Real time evolution of liquid crystalline nanostructure during the digestion of formulation lipids using synchrotron small-angle X-ray scattering. Langmuir. 2011;27(15):9528-34.
16. Patton JS et al. The light-microscopy of triglyceride digestion. Food Microstruct. 1985;4(1):29-41.
17. Rigler MW, Honkanen RE, Patton JS. Visualization by freeze fracture, in vitro and in vivo, of the products of fat digestion. J Lipid Res. 1986;27(8):836-57.
18. Rigler MW, Patton JS. The production of liquid-crystalline product phases by pancreatic lipase in the absence of bile salts - a freeze-fracture study. Biochim Biophys Acta. 1983;751(3):444-54.
19. Fatouros DG, Bergenstahl B, Mullertz A. Morphological observations on a lipid-based drug delivery system during in vitro digestion. Eur J Pharm Sci. 2007;31(2):85-94.
20. Fatouros DG et al. Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products. Pharm Res. 2009;26(2):361-74.
21. Mullertz A et al. Insights into intermediate phases of human intestinal fluids visualized by atomic force microscopy and cryo-transmission electron microscopy ex vivo. Mol Pharm. 2012;9(2):237-47.
22. Dubochet J et al. Cryo-electron microscopy of vitrified specimens. Q Rev Biophys. 1988;21(2):129-228.
23. Kaukonen A et al. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharm Res. 2004;21(2):254-60.
24. Gargouri Y, Moreau H, Verger R. Gastric lipases: biochemical and physiological studies. Biochim Biophys Acta. 1989;1006(3):255-71.
25. Dressman JB et al. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res. 1990;7(7):756-61.
26. Kratky O, Glatter O, editors. Small angle X-ray scattering. London: Academic; 1982.
27. Alvarez FJ, Stella VJ. The role of calcium-ions and bile-salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin. Pharm Res. 1989;6(6):449-57.
28. Schurtenberger P, Mazer N, Kanzig W. Micelle to vesicle transition in aqueous solutions of bile-salt and lecithin. J Phys Chem. 1985;89(6):1042-9.
29. Hofmann AF, Borgstrom B. Intraluminal phase of fat digestion in man - lipid content of micellar + oil phases of intestinal content obtained during fat digestion + absorption. J Clin Investig. 1964;43(2):247.
30. Soderlind E et al. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids. Mol Pharm. 2010;7(5):1498-507.
31. Christensen JO et al. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci. 2004;23(3):287-96.
32. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3-4):278-87.
33. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173-82.
34. Thomas N et al. Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems. J Pharm Sci. 2012;101(5):1721-31.
35. Gershanik T, Benita S. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm. 2000;50(1):179-88.
36. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000;11:S93-8.
37. Tan A et al. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol Pharm. 2010;7(2):522-32.
38. Tan A et al. Hybrid nanomaterials that mimic the food effect: controlling enzymatic digestion for enhanced oral drug absorption. Angew Chem Int Ed. 2012;51(22):5475-9.